Aster DM Healthcare Limited (ASTERDM) — Board Meeting Announcement

· NSE 🟡 Notable Neutral
📢 Key Event
Board approved audited standalone and consolidated financial results for Q4 and FY2026, declared interim dividend, and confirmed auditor's unmodified opinion.
🔄 What Changed
Net profit after tax increased to INR 0.65 crores (year) from prior period; total assets rose to INR 6,340.04 crores; interim dividend of INR 3 per share declared; provision for Kerala wage dispute reversed.
💡 Investor Takeaway
The company delivered modest profitability with asset growth and declared a dividend, but faces ongoing legal uncertainty around Kerala wage revisions.

The Board of Directors of Aster DM Healthcare Limited approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, along with the Auditor's Report confirming an unmodified opinion from Deloitte Haskins & Sells. Total income reached INR **2,770.73 crores** for the year and INR **695.65 crores** for the quarter, with net profit after tax of INR **0.65 crores** (year) and INR **0.21 crores** (quarter). Total assets grew to INR **6,340.04 crores** from INR **4,964.76 crores** a year earlier. The company declared an interim dividend of INR **3 per share** and reversed a provision of INR **25.41 crores** related to Kerala minimum wage disputes. Cash flow from operations was INR **387.13 crores**, though financing activities used INR **243.94 crores**, primarily due to dividend payments. The audit covered 28 consolidated entities, with Deloitte relying on other auditors for subsidiaries not directly audited.

📄 View Original Announcement (PDF)

About Aster DM Healthcare Limited (ASTERDM)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹39,048.19 Cr P/E: 7.1

View full ASTERDM stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.